Prevalence and Risk Factors Associated with Hepatitis B and Hepatitis C Infections among Patients Undergoing Hemodialysis: A Single-Centre Study in Somalia

Table 2

The prevalence of HBV and HCV in relation to demographic variables of the respondents.

Demographic variables		Negative	Hepatitis B positive	Hepatitis C positive	Both hepatitis B and C positive	Total
Age group	<20 years	13 (6.6%)	0 (0%)	1 (14.3%)	0 (0%)	14 (6.4%)
	21–40 years	35 (17.9%)	3 (18.75%)	0 (0%)	0 (0%)	38 (17.2%)
	41–60 years	72 (36.7%)	4 (25%)	2 (28.6%)	1 (100%)	79 (36%)
	61–80 years	76 (38.8%)	8 (50%)	4 (57.1%)	0 (0%)	88 (40%)
	>80 years	0 (0%)	1 (6.25%)	0 (0%)	0 (0%)	1 (0.4%)
	Total	196 (100%)	16 (100%)	7 (100%)	1 (100%)	220 (100%)
Gender	Male	97 (49.5%)	11 (68.7%)	4 (57%)	1 (100%)	113 (51.4%)
	Female	99 (50.5)	5 (31.3%)	3 (43%)	0 (0%)	107 (48.6%)
	Total	196 (100%)	16 (100%)	7 (100%)	1 (100%)	220 (100%)
Duration of dialysis	Less than 12 months	52 (26.5%)	0 (0%)	1 (14.3%)	0 (0%)	53 (24.1%)
	12–36 months	105 (53.5%)	5 (31.25%)	1 (14.3%)	0 (0%)	111 (50.4%)
	More than 36 months	39 (20%)	11 (68.75%)	5 (71.4%)	1 (100%)	56 (25.5%)
	Total	196 (100%)	16 (100%)	7 (100%)	1 (100%)	220 (100%)
No. of HD sessions/week	1 session/week	60 (30.6%)	0 (0%)	0 (0%)	0 (0%)	60 (27.3%)
	2 sessions/week	131 (66.8%)	6 (37.5%)	5 (71%)	0 (0%)	142 (64.5%)
	3 sessions/week	5 (2.6%)	10 (62.5%)	2 (29%)	1 (100%)	18 (8.2%)
	Total	196 (100%)	16 (100%)	7 (100%)	1 (100%)	220 (100%)
Blood transfusion	No blood transfusion	53 (27.04%)	1 (6.25%)	2 (28.6%)	0 (0%)	56 (25.5%)
	Less than 5 times transfused	83 (42.3%)	1 (6.25%)	1 (14.3%)	0 (0%)	85 (38.6%)
	5–10 times transfused	42 (21.42%)	6 (37.5%)	1 (14.3%)	0 (0%)	49 (22.2%)
	10–15 times transfused	17 (8.7%)	6 (37.5%)	1 (14.3%)	0 (0%)	24 (11%)
	More than 15 times transfused	1 (0.5%)	2 (12.5%)	2 (28.6%)	1 (100%)	6 (2.7%)
	Total	196 (100%)	16 (100%)	7 (100%)	1 (100%)	220 (100%)